Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Context: A majority of women with polycystic ovary syndrome (PCOS) have metabolic abnormalities that result in an increased risk of developing type 2 diabetes and heart disease. Correlative studies have shown an association between changes in the gut microbiome and metabolic disorders. Two recent studies reported a decrease in α diversity of the gut microbiome in women with PCOS compared with healthy women. Objective: We investigated whether changes in the gut microbiome correlated with specific clinical parameters in women with PCOS compared with healthy women. We also investigated whether there were changes in the gut microbiome in women with polycystic ovarian morphology (PCOM) who lacked the other diagnostic criteria of PCOS. Participants: Subjects were recruited at the Poznan University of Medical Sciences. Fecal microbial diversity profiles of healthy women (n = 48), women with PCOM (n = 42), and women diagnosed with PCOS using the Rotterdam criteria (n = 73) were analyzed using 16S ribosomal RNA gene sequencing. Results: Lower α diversity was observed in women with PCOS compared with healthy women. Women with PCOM had a change in α diversity that was intermediate between that of the other two groups. Regression analyses showed that hyperandrogenism, total testosterone, and hirsutism were negatively correlated with α diversity. Permutational multivariate analysis of variance in UniFrac distances showed that hyperandrogenism was also correlated with β diversity. A random forest identified bacteria that discriminated between healthy women and women with PCOS. Conclusion: These results suggest that hyperandrogenism may play a critical role in altering the gut microbiome in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In keeping with the developmental origins hypothesis previously discussed, maternal androgens may alter the composition and function of the microbiome, therefore facilitating the pathogenesis of PCOS [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although most studies are small, dysbiosis has consistently been found to correlate with different physiological parameters, such as obesity, sex hormones and metabolic defects [140,141,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study showed that beta diversity, which is used to measure differences between groups, was negatively correlated with hyperandrogenism, suggesting that androgens play a significant role in dysbiosis [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Decreased α-diversity has been described in women with PCOS [109, 110].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [110]
The cited source says what the claim attributes to it.
In the citing paper
“Dysbiosis is a consistent finding when looking at the microbiome of women with PCOS [140,141,142,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 48,949
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · cited 1×
“The resulting SVs were then aligned using MAFFT (21), and a phylogenetic tree was built using FastTree (22).”
MethodDADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 1×
“DADA2 software was used to obtain a set of observed sequence variants (SVs) (19).”
MethodQIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“6/) (18) using the q2-tools-import script, and sequences were demultiplexed using the q2-demux emp-single script.”
MethodSelf-citationAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Fecal microbiome transplantation from obese humans into germ-free mice also resulted in an obese phenotype, indicating a potential causative role of the gut microbiome in the development of metabolic disorders (13, 14).”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839 · cited 1×
“For each sample, the V4 hypervariable region of the 16S ribosomal RNA (rRNA) gene was polymerase chain reaction (PCR) amplified with primers 515F and 806R (16).”
MethodHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Cited by
Items 301–400 of 414
Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome
Zhu, T., & Li, X. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13814 · Cited by 2
Role of Microbiome in Reproductive Health: An Expanding Dimension
Pushkarna, S., Bhatnager, R., Kumar, A., Suneja, P., & Dang, A. S. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_16 · Cited by 3
Probiotic Interventions for Polycystic Ovarian Syndrome – A Comprehensive Review
Kochar, N. I., Solanke, S., & Chandewar, A. (2024) · Scholars International Journal of Obstetrics and Gynecology · doi:10.36348/sijog.2024.v07i06.001 · Cited by 2
“Specifically, PCOS patients often exhibit decreased microbial diversity, characterized by reduced richness and evenness of microbial species within the gut ecosystem [14].”
BackgroundFOODBORNE CARBON DOT-INDUCED GUT MICROBIOTA DYSBIOSIS LEAD TO REPRODUCTIVE TOXICITY IN MALE MICE
Chen, P., Ma, M., Chen, X., Xu, Z., Guo, J., Hu, X., Lv, L., Guo, J., & Liu, G. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.07.791 · Cited by 2
Толстова, А. С., Морозов, М. В., Родин, О. В., Фазилов, Н. А., Кох, А. А., & Безжонова, А. А. (2021) · Естественные и Технические Науки · doi:10.37882/2223-2966.2021.05.29 · Cited by 2
Metagenome datasets from women with polycystic ovary syndrome from Irkutsk, Eastern Siberia, Russia
Belkova, N. L., Станиславовна, К. Е., Vilson, N. I., Sambyalova, А. Y., Markova, D., Igumnov, I., & Сутурина, Л. В. (2020) · Data in Brief · doi:10.1016/j.dib.2020.106137 · Cited by 2
Zheng, Y., Xu, Y., Ma, H., Liang, C., & Yang, T. (2021) · Research Square · doi:10.21203/rs.3.rs-97809/v3 · Cited by 3
Ni, Z., Cheng, W., Ding, J., Yao, R., Zhang, D., Zhai, D., Zhou, L., & Yu, C. (2020) · Research Square · doi:10.21203/rs.3.rs-117891/v1 · Cited by 2
The Controversial Interplay of Gut Microbiome and Reproductive Function in Humans
CHRISTOPOULOS, P. F., Tsarna, E., & Domali, E. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_9 · Cited by 1
Management of Infertility in Overweight or Obese Polycystic Ovary Syndrome Patients
Ruan, X., Yang, Y., Gu, M., & Dhungel, P. (2023) · Reproductive medicine for clinicians · doi:10.1007/978-3-031-24903-7_19 · Cited by 1
Prevalence, Risk Factors and Management of Polycystic Ovary Syndrome: A Review with Current Evidence
Memon, S. I., Shakeel, M., Syed, H., Amin, K., Khalil, A. A., & Sulaiman, M. (2024) · Iraq Medical Journal · doi:10.22317/imj.v8i1.1268 · Cited by 3
“17,18 Thus, this review aims to provide a comprehensive analysis of recent literature on polycystic ovary syndrome (PCOS), focusing on prevalence, risk factors, and its prevention.”
BackgroundPCOS – The Importance of Diet, Physical Activity, and Other Non-Pharmacological Methods in Treatment
Turek, M., Wojciechowska, K., Jaroń, A., Jastrzębska, K., Wiklińska, A., Witkowska, M., Skotnicka, J., Błaszczak, K., Borkowski, A., & Sawicki, M. (2024) · Quality in Sport · doi:10.12775/qs.2024.19.53833 · Cited by 1
Bugs and babies: How gut microbiota affect infertility? A narrative Review
Nabeh, O. A., Menshawey, R., Menshawey, E., & Moubarak, E. S. (2025) · Urologia Journal · doi:10.1177/03915603251358953 · Cited by 1
“50,51 Provotella species were also found to be higher in PCOs and were positively associated with inflammation androgen, and a negatively regulated estradiol.”
Exploring the interactions of gut microbiome and metabolites in polycystic ovary syndrome: a review
Li, J., Jia, Y., Xu, H., Bing, H., Ling, Q., Wang, S., Wang, Y., Zhang, X., & Zhao, L. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128309 · Cited by 1
Nutritional Supplements as PCOS Intervention
Bashir, R., & Ganie, M. A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010009 · Cited by 1
Cross-talking between polycystic ovarian syndrome and gut microbiome: a comprehensive review
Choudhury, S. R., Koner, S., & Dey, R. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00304-6 · Cited by 1
Sparić, R., Andjić, M., Tinelli, A., Pecorella, G., Ilic, D. S., Livadas, S., Radić, L., Mastorakos, G., & Bjekić-Macut, J. (2026) · HORMONES · doi:10.1007/s42000-026-00762-7 · Cited by 1
“Torres et al. analyzed the gut microbiome in three groups of women: those with isolated polycystic ovarian morphology (PCOM), those diagnosed with polycystic ovary syndrome (PCOS), and healthy controls [53 ].”
Microecological modulators—new perspectives for treating sex hormone disorders
Li, X., Yu, X., Zhong, Y., Zhou, G., & Zhou, G. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1795152 · Cited by 1
“Hyperandrogenism has been shown to alter the gut microbiome in women with polycystic ovary syndrome (PCOS) (Torres et al., 2018).”
Mukadam, S. S., Singh, S. P., Tiyasha, T., Jain, G., Jangid, A., Gupta, R., & Kumar, V. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00330-4 · Cited by 2
“Reduced SCFA production also weakens gut barrier integrity and diminishes metabolic regulation, further promoting metabolic dysfunction [58, 59].”
Wang, H., Chen, W., Li, X., Lu, X., Liu, T., Liang, J., Wang, Y., Jia, M., Zhang, R., Gu, Y., et al. (2026) · iMetaMed · doi:10.1002/imm3.70047 · Cited by 1
Ravat, F. K., Nair, S. M., Gandhi, M., Ninama, P. G., Punjabi, S., Shah, D., Sheth, D. B., Patel, B., Maheriy, B. K., & Thummar, K. N. (2026) · Steroids · doi:10.1016/j.steroids.2026.109831 · Cited by 1
Peng, H., Jiang, J., Wang, Z., & Wang, W. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02201-y · Cited by 1
Gordon, B., Agresta, E., Isoldi, K. K., & Vargas-Rodriguez, I. (2019) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000196 · Cited by 1
INFLUÊNCIA DO EXCESSO PONDERAL SOBRE A FISIOPATOLOGIA DA SÍNDROME DOS OVÁRIOS POLICÍSTICOS
de Oliveira, N. S., Nascimento, J. M. D. S., & Melo, N. C. D. O. (2022) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v3i1.1049 · Cited by 1
Xie, J., Cao, Y., Wen, Q., Song, X., Shi, Y., & Gao, X. (2024) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2024.1468471 · Cited by 2
Zheng, Y., Xu, Y., Ma, H., Liang, C., & Yang, T. (2020) · Research Square · doi:10.21203/rs.3.rs-97809/v2 · Cited by 1
5 Infertility and assisted reproduction
Maclean, A. (2004) · Routledge eBooks · doi:10.4324/9781843148913-19 · Cited by 1
Huang, J., Su, C.-L., Zhang, X., Dai, R., Jiang, L., Zhang, T., Sun, Y. P., & Zhu, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1833351/v1 · Cited by 1
Zoltán, K. I., Kun, I., & Kolcsár, M. (2019) · Orvostudományi Értesítö · doi:10.2478/orvtudert-2019-0016 · Cited by 1
Mikrobiom und Stoffwechsel beim polyzystischen Ovarialsyndrom (PCOS)
Heizmann, W. R., & Keck, C. (2021) · Der Gynäkologe · doi:10.1007/s00129-021-04829-x
Семантика артикуляционных приёмов в хоровом дирижировании
Зиновьева, Л. П. (2010) · Мир науки, культуры, образования
Zheng, Y., Ma, H., Xu, Y., Liang, C., & Yang, T. (2020) · Research Square · doi:10.21203/rs.3.rs-97809/v1
“Hyperandrogenism may play an important role in altering the gut microbiome in women with PCOS [4].”
BackgroundIslam, R., & Saha, T. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123975123010004
Perspectives of PCOS Pathophysiology: Exploring the Interplay between PCOS and the Gut Microbiota
Khade, K., Dadachanji, R., & Mukherjee, S. (2023) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34986
The gut microbiota—as an endocrine organ
Kumar, P., & McEwan, I. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91141-2.00009-x
Teplova, A. S., Demidova, T. Y., & Геннадьевна, Л. К. (2023) · FOCUS Endocrinology · doi:10.15829/2713-0177-2023-3-15
Features of the Gut Microbiota in Patients with Polycystic Ovary Syndrome
Дмитриевна, К. Е., Muravieva, V. V., Леонидовна, И. Е., Skorobogatiy, A. V., Zhigalova, K. N., Kozlova, A. A., Priputnevich, T. V., & Евгеньевна, Ч. Г. (2023) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn6442 · Cited by 1
Chestnut polysaccharides rescue impaired spermatogenesis by adjusting gut microbiotaPreprint
Sun, Z., Yu, S., Tian, Y., Han, B., Zhao, Y. M., Li, Y., Wang, Y., Sun, Y., & Shen, W. (2024) · Authorea · doi:10.22541/au.170668093.35367017/v1
Yang, J., Wang, E., Jiang, M., Tan, Y., Yao, F., Sun, C., Pan, L., Gao, L., & Yao, J. (2023) · Figshare · doi:10.6084/m9.figshare.23298948
Pan, L., Shuai, P., Shen, S., Zheng, H., Sun, P., Zhang, R., Lan, S., Lan, Z., Jayawardana, T. C., Yang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916814
Introduction to gut microbiome and epigenetics
Oshinjo, A. M., Michael, O. S., Adedayo, L. D., Adetunji, C. O., Bamidele, O., Adetunji, J. B., Morakinyo, A., Akinwale, E. O., Ajayi, O. O., Awobajo, F. O., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00009-6
Polytechnic Overeat Sintrems and Disease
Bhushan, S. R. P. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23514113131
Study thyroid gland hormones in female with polycystic ovary syndrome: A Review
Hasan, I. J. H. (2024) · University of Thi-Qar Journal of agricultural research · doi:10.54174/utjagr.v13i1.298
Polycystic ovary syndrome: pathogenic mechanisms and nutritional therapeutic strategies
Zhao, Y., Liu, B., Zhao, J., Liu, Y., Pan, H., Yuan, Y., Tian, X., Qiao, W., Zhang, Z., & Chen, L. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250269 · Cited by 1
Role of Gut Microbiota in Polycystic Ovary Syndrome
Dhiman, S., Gupta, A. A., & Garg, R. (2024) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2466
王, 钰. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1482299
Gut microbiota biodiversity indices as markers of hyperandrogenemia in women of reproductive age
Igumnov, I. A., Belkova, N. L., Atalyan, A. V., Станиславовна, К. Е., Sholokhov, L. F., Belenkaia, L. V., Samarina, Y. M., Николаевна, Д. И., Лазарева, Л. М., Nadeliaeva, I. G., et al. (2024) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2024-9.4.2 · Cited by 1
The Affections of Bacteria in the Gut Upon Polycystic Ovary Syndrome
Dakhil, Z. F. (2025) · Scholars Academic Journal of Biosciences · doi:10.36347/sajb.2025.v13i05.010
“Prebiotics are food components that cannot be digested but foster the development of helpful gut bacteria [14][27].”
InfluentialSoni, A., Parikh, M., & Gandhi, T. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00013-9
Kumaravelu, R., Dhevi, B., & Thulasi, A. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20252719
Ma, M., Liu, G., Wang, K., Cao, T., Shen, L., Hou, S., Xi, X.-X., & Feng, H. (2025) · Research Square · doi:10.21203/rs.3.rs-7003646/v1
A Gut Microbiota Perspective on the Sweet and Warmth Therapy for Heat Clearance in Acne Management
郑, 素. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1592466
Liu, Y., Wang, Q., Han, L., Shao, X., Wang, X., Liu, X., Wang, J., Luo, S., & Lu, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1581504
Exploring the Role of Abnormal Qi Movement in Polycystic Ovary Syndrome Based on the Gut-Brain Axis
高, 惠. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15113141
Moderne Mayr-Medizin in der gynäkologischen Praxis: Prinzipien und physiologische Hintergründe
Hohmann, C. (2025) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-025-00426-6
Protective effects of nutritional and polyphenolic supplementation in polycystic ovarian syndromes
Joshi, S., Munjal, K., Saxena, G., & Chitme, H. R. (2025) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2025.12.005 · Cited by 4
Fan, H., Hong, X., Zeng, J., Wang, X., & Chen, J. (2021) · Figshare · doi:10.6084/m9.figshare.14992996
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551578
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551569
Zhou, Z., Feng, Y., Xie, L., Ma, S., Cai, Z., & Ma, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25025824
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551566
Li, P., Shuai, P., Shen, S., Zheng, H., Sun, P., Zhang, R., Lan, S., Lan, Z., Jayawardana, T. C., Yang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916808
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551575
Han, Q., Wang, J., Li, W., Chen, Z.-J., & Du, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14551572
Shah, R. S. (2023) · eScholarship (California Digital Library)
Lee, S. (2024) · DSpace repository (University of Tartu)
Gut and Vaginal Microbiome Dysbiosis in PCOS
Kottahachchi, D., Subasinghe, C., & Bajaj, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010021
Mir, B., Bashir, S., Shah, I., Geer, M. I., & Ganie, M. A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010011
García Beltran, C. (2024) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Mustari, M., Kamrul-Hasan, A. B. M., Tanni, A. Z., Ahammed, A., Raunak, A. I. B., Afsana, F., Pathan, M. F., Saifuddin, M., Rahman, M. M., Akter, N., et al. (2025) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_38_25
Covataru, N.-A. (2025) · The Romanian Journal of Nutrition. · doi:10.26416/journutri.8.4.2025.11267
Kulkarni, N., Jalan, S. K., & Kumar, V. (2025) · International Conference on Computing, Communication and Automation · doi:10.1109/iccca66364.2025.11325458
“Meta-analyses confirm that microbiome-targeted interventions, although preliminary, show therapeutic potential [10], [11], [12], [13].”
Goyal, N., Sharma, S., Bhatia, R., & Gupta, S. (2026) · Current Drug Metabolism · doi:10.2174/0113892002424403251122104355
Sil, S., Ghosh, A., Kar, T. K., Halder, S. K., & Chattopadhyay, S. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104865
Role of Gut Microbiota in Menstrual Dysregulation in Polycystic Ovary Syndrome
Gayaki, U., Madireddy, L., & Nishane, D. (2026) · International Conference on AI-Driven Smart Systems and Ubiquitous Computing (ICAUC) · doi:10.1109/icauc68182.2026.11441138
“Bet diversity analysis that estimates the divergence among microbial communities tends to indicate an immense segregation in the manner of cluster among communities, unveiling characteristic profiling for PCOS [11],[25] .”
Suturina, L., Belkova, N. L., Sidorova, T. V., Евгеньевна, С. Н., Igumnov, I., Lazareva, L., Николаевна, Д. И., Nadeliaeva, I. G., Sholokhov, L. F., Belenkaia, L. V., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072974
“Available data on gut microbiota biodiversity primarily support a decrease in the values of at least one of the alpha diversity indices in PCOS, while the scientific findings regarding the diversity differences between non-androgenic and hyperandrogenic women are contradictory [3,5,11–21].”
Lv, Y., Li, D., Ding, N., & Kuang, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1730795 · Cited by 1
“Patients with PCOS display characteristic gut microbiota dysbiosis, though specific compositional alterations remain inconsistently reported across studies (36, 37).”
Microbial Endocrinology: The Influence of the Gut Microbiome on Metabolic and Endocrine Health
Zaet, A., Aswehlee, A. M., & Zeat, K. (2024) · Open Journal of Biomedical Research · doi:10.26629/ojbr.2024.04
THE ROLE OF GUT MICROBIOTA IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME
Stępień, A., Podleśna, M., Bączek, K., Chromiak, K., Curzytek, K., Bluczak, K., Czechowicz, K., Radziwiłko, J. M., Pastuszak, A., & Kozińska, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4524
Metformin improves endotoxemia and alters folliculogenesis in women with polycystic ovary syndrome
Trzcinski, M., Chudzicka-Strugała, I., Kim, K. K., Piekarski, P., Spaczyński, R., Zwoździak, B., Banaszewska, B., Pawelczyk, L. A., Chang, R. J., & Dulęba, A. J. (2026) · Endocrine Connections · doi:10.1530/ec-26-0120 · Cited by 1
“Indeed, consistent with this theory, we and other investigators found that PCOS is characterized by gut dysbiosis (5, 6, 7, 8).”
Self-citationBegum, M. N., Krishnan, M., Lalithamma, A., & Jyothi, V. (2026) · International Research Journal of Multidisciplinary Scope · doi:10.47857/irjms.2026.v07i02.010798
Metabolic aspects of polycystic ovary syndrome
Pappas, D., Kandaraki, E., Kalogirou, A., & Diamanti‐Kandarakis, E. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2656240
“Several studies report a relative decrease in beneficial short-chain fatty acid (SCFA)-producing genera, such as Faecalibacterium and Bifidobacterium , alongside an increase in taxa associated with metabolic dysfunction, including Bacteroides and Prevotella [66,67].”
Li, Y. Y., He, F.-F., Donge‐Liu, Bin‐Xu, & Shuyi‐Li (2026) · Health Science Reports · doi:10.1002/hsr2.72593
Chmaj-Wierzchowska, K., Bednarek, K., Serbin, B., Staszewska, J., Graś, J., Żmuda, K., Makarewicz, A., Zamojcin, O., Mruczyński, A., & Wilczak, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124540
Sanna, S., Faro, V. L., Forabosco, P., Crobu, F., Carta, A., Busonero, F., Maschio, A., Viscito, M., Lenarduzzi, S., Vriz, G. B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9888793/v1
Tunjungseto, A., Hadi, O. A., Pratiwi, I. W., Iffatunnisa, F., Ahsan, F., & Santoso, B. (2026) · Diagnostics · doi:10.3390/diagnostics16132041
Casanova-Crespo, S., Ceballos-Sánchez, D., Vallverdú‐Queralt, A., Rodríguez-Lagunas, M. J., Massot‐Cladera, M., Castell, M., & Pérez-Cano, F. J. (2026) · Nutrients · doi:10.3390/nu18132088
“Dysbiosis and reduced microbial diversity have been linked to disorders affecting female reproductive health and fertility, including polycystic ovary syndrome, endometriosis, and unexplained infertility in both humans and animal models [60,61].”
Therapeutic potential of natural products in polycystic ovary syndrome
Bai, C., & Liu, J. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12324-6
“Research confirms that women with PCOS exhibit gut microbiota dis - ruption characterized by dysbiosis and reduced microbial diversity [95], leading to functional imbalance and disrupted homeostasis.”
Duodenal microbiome profiles exhibit sex-specific differences
Rashid, M. A., Leite, G., Barlow, G. M., Hosseini, A., Brimberry, D., Flor, D., Parodi, G., Sanchez, M., Rivera, I., Trujillo, A., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116679
Ni, M., Wang, Q., Ye, T., Lei, H., Wang, Y., & Yuan, Y. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02164-0
“PCOS patients exhibit specific microbial profiles (e.g., reduced Prevotella, increased Bacteroides) significantly correlated with IR severity [23].”
Romeo, M., D’Urso, F., Paladini, F., Pollini, M., Chieppa, M., & Broccolo, F. (2026) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2026.14711
Gut microbiota and polycystic ovary syndrome: Pathogenesis and novel therapeutic approaches
Zhu, T., Sha, Y., Wang, Q., Yang, H., & Liu, T. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128643
Guijarro, L. E. O., Ojeda, G. D. M., Bonifaz, M. X. V., & Borja, I. G. M. (2026) · Tesla Revista Científica · doi:10.55204/trc.v6i2.e702
Singla, J., Yadav, S., & Gayen, J. R. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104943 · Cited by 1
Huang, X., Chen, Z., Zhang, L., & Li, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797826
Gao, Y., Liu, C., & He, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1840605
“The information in this table is compiled from references (Liu et al., 2017; Torres et al., 2018; Qi et al., 2019; Zhou et al., 2020; Zhu et al., 2021). intestinal lymphocytes to respond to secondary BA stimulation.”
Gonzalez-Rodriguez, L. A., Jimenez-Ortega, K. M., Vargas-Robles, D., Martinez-Hernandez, C. I., Meléndez-Vázquez, N. M., Romaguera, J., & Godoy‐Vitorino, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1890094
Nowakowski, Ł., Warchoł, K., Kuźniar, A., Zimoń, B., Skoczylas, M. M., Marzec, P., Krawczyk, G., Jegorow, D., Pankiewicz, R., Warchol, A., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176705
“Possibly a decrease in functional specialization, less flexibility in metabolizing drugs or hormones [63,72,82,92,101,110,111,118] https://doi.org/10.3390/jcm15176705 This scoping review has several limitations.”
InfluentialSuresh, A., Jayaprakasan, J., Venkatesan, R., Soujanya, C., & Selvaraj, D. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107117
The Microbiome-Metabolome Axis in Polycystic Ovary Syndrome.
Saldívar-Cerón, H. I. (2026) · The Journal of Reproduction · doi:10.58779/tjorvol4num1/2
Metadata
- Authors
- Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G.
- Affiliations
- San Diego State University (US)
- Poznan University of Medical Sciences (PL)
- Department of Reproductive Medicine, University of California, San Diego, La Jolla, California
- University of California San Diego (US)
- Corresponding author
- Thackray, Varykina G
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-01-23
- Volume
- 103
- Issue
- 4
- Pages
- 1502-1511
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6276580
- OpenAlex
- W2792000617
- Cited by
- 399
- References
- 42
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 69 · 2023: 55 · 2022: 44 · 2021: 57 · 2020: 37 · 2019: 20 · 2018: 5
- FWCI
- 31.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD012303, R01HD082567)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- polycystic ovary syndrome, gut microbiota, hyperandrogenism, alpha diversity, beta diversity, polycystic ovary morphology, hirsutism, total testosterone, fecal microbiota, 16S rRNA gene sequencing, type 2 diabetes risk, metabolic disorders
- MeSH terms
- Gastrointestinal Microbiome, Adult, Feces, Female, Humans, Polycystic Ovary Syndrome, RNA, Ribosomal, 16S, Hyperandrogenism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.